FDA Approves Omvoh for Ulcerative Colitis
Learn more about the approval of a new drug, Omvah ((mirikizumab-mrkz), for people with moderately to severely active ulcerative colitis.
THIOPURINE MEDICATIONS ARE LINKED WITH RISK OF SEVERE COVID-19 IN INFLAMMATORY BOWEL DISEASE PATIENTS
HOW INFLAMMATORY BOWEL DISEASE CAN AFFECT THE EYES
WHAT IS THE MICROBIOME AND WHY DOES IT MATTER FOR IBD?
WHAT IS THE SPECIFIC CARBOHYDRATE DIET AND DOES IT REALLY WORK?